Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
However, a case report published in the Journal of the American Pharmacists Association documented a patient who developed anti-NMDA receptor autoimmune encephalitis after five weeks of tirzepatide treatment
Zhao H-J, Jiang X, Hu L-J, Yang L, Deng L-D, Wang Y-P, et al
doi: 10.1097/prs.0000000000007783 7 SchaverienMVAsaadMSelberJCLiuJChenDNHallMSet al
Nature Rev (2024) mechanistic review
What this means for members Patients with IBX plans who are currently taking a GLP-1 or non-GLP-1 drug for weight loss and want to continue taking the medication will be responsible for the full cost of the drug beginning January 1, 2025, or when their coverage plan renews
It is worth noting that even among those men with levels between 40-50 U/I, a level considered to be in the normal range, a nearly 20-fold increase in risk was found
US$ 28.22
US$ 26.50
US$ 26.22
US$ 23.34
US$ 27.05
